Comparison of P-glycoprotein-mediated drug–digoxin interactions in Caco-2 with human and rodent intestine: Relevance to in vivo prediction
- 1 December 2005
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 26 (5) , 386-393
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Predicting P-Glycoprotein Effects on Oral Absorption: Correlation of Transport in Caco-2 with Drug Pharmacokinetics in Wild-Type and mdr1a(-/-) Mice in VivoPharmaceutical Research, 2004
- Association between the number of coadministered P-glycoprotein inhibitors and serum digoxin levels in patients on therapeutic drug monitoringBMC Medicine, 2004
- Clinical Aspects of the MDR1 (ABCB1) Gene PolymorphismTherapeutic Drug Monitoring, 2004
- P-Glycoprotein-based drug-drug interactions: preclinical methods and relevance to clinical observationsArchives of Pharmacal Research, 2004
- Transporter-Enzyme Interactions: Implications for Predicting Drug-Drug Interactions from In Vitro DataCurrent Drug Metabolism, 2003
- P‐glycoprotein‐mediated intestinal and biliary digoxin transport in humansClinical Pharmacology & Therapeutics, 2003
- Comparative Studies on in Vitro Methods for Evaluating in Vivo Function of MDR1 P-GlycoproteinPharmaceutical Research, 2001
- A Functional Assay for Quantitation of the Apparent Affinities of Ligands of P-Glycoprotein in Caco-2 CellsPharmaceutical Research, 2001
- Inhibition of P-Glycoprotein–Mediated Drug TransportCirculation, 1999
- Digoxin bioavailability during quinidine administrationClinical Pharmacology & Therapeutics, 1981